🔗 Permalink

Inventor profile of:

Michael Bukrinsky

City:

Potomac, Maryland

Country:

United States

Published Applications:

7

Last publication date:

2021-12-30

Top Assignees for applications by Michael Bukrinsky

The entities that hold a legal rights for patent applications filed by inventor Bukrinsky Michael:

The George Washington University 3 Washington, DC United States
Max-Planck-Gesellschaft zur Foerderung der Wissenschaften e.V. 1 Munich, Germany
LEAD DISCOVERY CENTER GMBH 1 DORTMUND, Germany
Max-Planck-Gesellschaft zur Forderung der Wissenschaften E.V. 1 Munich, Germany
LEAD DISCOVER CENTER GMBH 1 Dortmund, Germany
MAX-PLANCK-GUSELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V. 1 München, Germany
The George Washington University a Congressionally Chartered Not-for Profit Corporation 1 Washington, DC United States
CORPORATION 1 Washington, DC United States
THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONLLY CHARTERED NOT-FOR-PROFIT CORPORATION 1 Washington, DC United States

Recent patent applications by Bukrinsky Michael

Michael Bukrinsky from Potomac, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2021-12-30

US20210405029A1

Compounds inhibiting Nef-calnexin interaction

#2 | 2020-10-29

US20200340977A1

Compounds inhibiting Nef-calnexin interaction

#3 | 2019-01-31

US20190033297A1

Compounds inhibiting Nef-calnexin interaction

#4 | 2014-10-23

US20140316104A1

Chemistry; metallurgy

Cyclosporin derivatives

#5 | 2012-08-02

US20120196749A1

Chemistry; metallurgy

Cyclosporin derivatives

#6 | 2011-02-10

US20110033446A1

Human necessities

Method of suppressing human immunodeficiency virus (HIV) replication in a subject by administering a liver X receptor (LXR) agonist

#7 | 2009-10-15

US20090258024A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF CHRONIC INFLAMMATORY DISEASES

InventorID:

946134 ⎘